Banerjee Subhashis
Known title: Chief Medical OfficerCIK: 0002065633
Associated companies
Transaction History
| ARTV | ▼ Sell | Open Market | 1,099 | $8K | 10/5/2026 | View on chart |
| ARTV | ▲ Buy | Grant | 30,000 | $0 | 9/9/2026 | View on chart |
| ARTV | ▼ Sell | Open Market | 1,100 | $12K | 9/3/2026 | View on chart |
| ARTV | ▲ Buy | Option Exercise | 5,306 | $10K | 8/27/2026 | View on chart |
| ARTV | ▼ Sell | Open Market | 8,222 | $99K | 8/27/2026 | View on chart |
| ARTV | ▲ Buy | Option Exercise | 429 | $824 | 8/18/2026 | View on chart |
| ARTV | ▼ Sell | Open Market | 429 | $5K | 8/18/2026 | View on chart |
| ARTV | ▼ Sell | Open Market | 7,037 | $63K | 5/19/2026 | View on chart |
| ARTV | ▲ Buy | Grant | 102,000 | $0 | 2/15/2026 | View on chart |
| ARTV | ▲ Buy | Grant | 50,000 | $0 | 4/8/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
ARTV Announces Oral Presentation of AlloNK Data at Sjögren’s Symposium
Artiva Biotherapeutics will give an oral presentation of its AlloNK® clinical data at the 17th International Symposium on Sjögren’s Disease. The talk focuses on early results from a study in patients with this autoimmune disorder. The data could influence how investors view the company’s therapeutic pipeline. The presentation is a milestone before any formal publication or regulatory filing.
ARTV Announces Oral Presentation of AlloNK Data at Sjögren’s Symposium. Artiva Biotherapeutics will give an oral presentation of its AlloNK® clinical data at the 17th International Symposium on Sjögren’s Disease. The talk focuses on early results from a study in patients with this autoimmune disorder. The data could influence how investors view the company’s therapeutic pipeline. The presentation is a milestone before any formal publication or regulatory filing.